268 related articles for article (PubMed ID: 30588609)
1. Sirtuin 3 suppresses the formation of renal calcium oxalate crystals through promoting M2 polarization of macrophages.
Xi J; Chen Y; Jing J; Zhang Y; Liang C; Hao Z; Zhang L
J Cell Physiol; 2019 Jul; 234(7):11463-11473. PubMed ID: 30588609
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LINC01197 inhibited the formation of calcium oxalate-induced kidney stones by regulating miR-516b-5p/SIRT3/FOXO1 signaling pathway.
Xi J; Chen Y; Jing J; Qi W; Zhang Y
Cell Tissue Res; 2023 May; 392(2):553-563. PubMed ID: 36688989
[TBL] [Abstract][Full Text] [Related]
3. SIRT3 improves alveolar epithelial cell damage caused by bronchopulmonary dysplasia through deacetylation of FOXO1.
Zang L; Chi J; Bi S; Tao Y; Wang R; Li L
Allergol Immunopathol (Madr); 2023; 51(2):191-204. PubMed ID: 36916106
[TBL] [Abstract][Full Text] [Related]
4. Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals.
Zhu W; Zhao Z; Chou F; Zuo L; Liu T; Yeh S; Bushinsky D; Zeng G; Chang C
Cell Death Dis; 2019 Mar; 10(4):275. PubMed ID: 30894518
[TBL] [Abstract][Full Text] [Related]
5. Effect of M2 Macrophages on Injury and Apoptosis of Renal Tubular Epithelial Cells Induced by Calcium Oxalate Crystals.
Liu Q; Liu Y; Guan X; Wu J; He Z; Kang J; Tao Z; Deng Y
Kidney Blood Press Res; 2019; 44(4):777-791. PubMed ID: 31408871
[TBL] [Abstract][Full Text] [Related]
6. SIRT3 inhibited the formation of calcium oxalate-induced kidney stones through regulating NRF2/HO-1 signaling pathway.
Xi J; Jing J; Zhang Y; Liang C; Hao Z; Zhang L; Chen Y
J Cell Biochem; 2019 May; 120(5):8259-8271. PubMed ID: 30548662
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of sirtuin 1 attenuates calcium oxalate-induced kidney injury by promoting macrophage polarization.
Song BF; Li BJ; Ning JZ; Xia YQ; Ye ZH; Yuan TH; Yan XZ; Li L; Zhou XJ; Rao T; Li W; Cheng F
Int Immunopharmacol; 2023 Aug; 121():110398. PubMed ID: 37301123
[TBL] [Abstract][Full Text] [Related]
8. Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury.
Ye QL; Wang DM; Wang X; Zhang ZQ; Tian QX; Feng SY; Zhang ZH; Yu DX; Ding DM; Xie DD
Chem Biol Interact; 2021 Sep; 347():109605. PubMed ID: 34333021
[TBL] [Abstract][Full Text] [Related]
9. Colony-stimulating factor-1 signaling suppresses renal crystal formation.
Taguchi K; Okada A; Kitamura H; Yasui T; Naiki T; Hamamoto S; Ando R; Mizuno K; Kawai N; Tozawa K; Asano K; Tanaka M; Miyoshi I; Kohri K
J Am Soc Nephrol; 2014 Aug; 25(8):1680-97. PubMed ID: 24578130
[TBL] [Abstract][Full Text] [Related]
10. Short Chain Fatty Acids Prevent Glyoxylate-Induced Calcium Oxalate Stones by GPR43-Dependent Immunomodulatory Mechanism.
Jin X; Jian Z; Chen X; Ma Y; Ma H; Liu Y; Gong L; Xiang L; Zhu S; Shu X; Qi S; Li H; Wang K
Front Immunol; 2021; 12():729382. PubMed ID: 34675921
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory role of microRNA-484 in kidney stone formation by repressing calcium oxalate crystallization via a VDR/FoxO1 regulator axis.
Fan L; Li H; Huo W
Urolithiasis; 2022 Dec; 50(6):665-678. PubMed ID: 36227295
[TBL] [Abstract][Full Text] [Related]
12. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis.
Liu H; Yang X; Tang K; Ye T; Duan C; Lv P; Yan L; Wu X; Chen Z; Liu J; Deng Y; Zeng G; Xing J; Ye Z; Xu H
Theranostics; 2020; 10(16):7319-7334. PubMed ID: 32641994
[TBL] [Abstract][Full Text] [Related]
13. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
[No Abstract] [Full Text] [Related]
14. Autophagy-endoplasmic reticulum stress inhibition mechanism of superoxide dismutase in the formation of calcium oxalate kidney stones.
Kang J; Sun Y; Deng Y; Liu Q; Li D; Liu Y; Guan X; Tao Z; Wang X
Biomed Pharmacother; 2020 Jan; 121():109649. PubMed ID: 31733571
[TBL] [Abstract][Full Text] [Related]
15. Vitexin exerts protective effects against calcium oxalate crystal-induced kidney pyroptosis in vivo and in vitro.
Ding T; Zhao T; Li Y; Liu Z; Ding J; Ji B; Wang Y; Guo Z
Phytomedicine; 2021 Jun; 86():153562. PubMed ID: 33857849
[TBL] [Abstract][Full Text] [Related]
16. AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization.
Yang X; Liu H; Ye T; Duan C; Lv P; Wu X; Liu J; Jiang K; Lu H; Yang H; Xia D; Peng E; Chen Z; Tang K; Ye Z
Theranostics; 2020; 10(26):12011-12025. PubMed ID: 33204326
[TBL] [Abstract][Full Text] [Related]
17. Re: Sirtuin 3 Suppresses the Formation of Renal Calcium Oxalate Crystals through Promoting M2 Polarization of Macrophages.
Assimos DG
J Urol; 2019 May; 201(5):852-853. PubMed ID: 31009979
[No Abstract] [Full Text] [Related]
18. M1/M2-macrophage phenotypes regulate renal calcium oxalate crystal development.
Taguchi K; Okada A; Hamamoto S; Unno R; Moritoki Y; Ando R; Mizuno K; Tozawa K; Kohri K; Yasui T
Sci Rep; 2016 Oct; 6():35167. PubMed ID: 27731368
[TBL] [Abstract][Full Text] [Related]
19. Macrophage Function in Calcium Oxalate Kidney Stone Formation: A Systematic Review of Literature.
Taguchi K; Okada A; Unno R; Hamamoto S; Yasui T
Front Immunol; 2021; 12():673690. PubMed ID: 34108970
[TBL] [Abstract][Full Text] [Related]
20. CCR2 antagonist attenuates calcium oxalate-induced kidney oxidative stress and inflammation by regulating macrophage activation.
Wang X; Xie L; Liu C
Exp Anim; 2024 May; 73(2):211-222. PubMed ID: 38199255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
